Medicare Enrolled

Dr. Yuichiro Hayashi, MD

Anesthesiology · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
757 WESTWOOD PLZ STE 3325, Los Angeles, CA 90095
3102678628
In practice since 2013 (12 years)
NPI: 1225471048 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hayashi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hayashi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hayashi

Dr. Yuichiro Hayashi is an anesthesiology specialist in Los Angeles, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Hayashi performed 353 Medicare services across 266 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hayashi received a total of $4,502 from 26 pharmaceutical and/or device companies across 84 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hayashi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 12% volume in CA $4,502 industry payments

Medicare Practice Summary

Medicare Utilization ↗
353
Medicare services
Top 12% in CA for anesthesiology
266
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~29 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
170 $98 $645
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
65 $74 $290
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
47 $132 $542
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
31 $91 $335
X-ray of lower and sacral spine, minimum of 4 views
An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints.
14 $42 $260
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
13 $103 $3,381
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
13 $145 $921
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,502
Total received (2018-2024)
Avg $750/year across 6 years
Top 6% in CA for anesthesiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
84
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,486 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$251
2023
$470
2022
$139
2020
$536
2019
$1,411
2018
$1,694

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$160
BIOTRONIK NRO, Inc.
$37
Avanos Medical
$19
Abbott Laboratories
$19
Nalu Medical, Inc.
$17
Top 3 companies account for 85.8% of 2024 payments
All-time payments by company (2018-2024) ›
Vertiflex, Inc.
$853
Medtronic USA, Inc.
$667
Nevro Corp.
$594
Boston Scientific Corporation
$580
Abbott Laboratories
$431
Stimwave Technologies Incorporated
$394
Avanos Medical
$336
Nalu Medical, Inc.
$143
SPR Therapeutics, Inc
$115
Daiichi Sankyo Inc.
$76
Medtronic, Inc.
$40
BIOTRONIK NRO, Inc.
$37
Saol Therapeutics Inc.
$27
Shionogi Inc
$25
PFIZER INC.
$24
Assertio Therapeutics, Inc.
$23
Saluda Medical Americas, Inc.
$18
Stryker Corporation
$15
Amgen Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$15
INSYS Therapeutics Inc
$14
ASSERTIO THERAPEUTICS, Inc.
$13
BioDelivery Sciences International, Inc.
$12
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$12
Scilex Pharmaceuticals Inc.
$12
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 47.0% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · ADAPTIVESTIM · ASCENDA · Aimovig · BUNAVAIL 2.1 mg 30-count box · CFNS StimQ Peripheral Nerve StimulatorSystem · COOLIEF COOLED RADIOFREQUENCY · Cambia · DRG IPGs · Evoke SCS · FREESTYLE LIBRE 2 · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GENERATOR · GENVISC 850 SODIUM HYALURONATE · Gralise · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · IVS - VERTEBRAL AUGMENTATION PRODUCTS · LUCEMYRA · LYRICA · Lioresal Intrathecal (baclofen injection) · MYSTIM · Morphabond ER · Nalu Neurostimulation System · OCTRODE · PROCLAIM · Proclaim Family of SCS IPGs · Prospera · RESTORE · SCS IPGs · SCS leads · SPECIFY · SPRINT PNS System · SUBSYS · Senza Spinal Cord Stimulation System · Superion ISS · Symproic · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for anesthesiology in CA.

Looking for an anesthesiology specialist in Los Angeles?
Compare anesthesiologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse anesthesiologists nearby

Geographic Context

Anesthesiologists within 10 mi
1,791
Per 100K population
18.2
County median income
$87,760
Nearest hospital
RONALD REAGAN UCLA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hayashi is a clinical cardiology specialist, with above-average Medicare volume (top 12% in CA), with low-engagement industry engagement in the top 6% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hayashi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hayashi performed 170 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hayashi receive payments from pharmaceutical companies?
Yes. Dr. Hayashi received a total of $4,502 from 26 companies across 84 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hayashi's costs compare to other anesthesiologists in Los Angeles?
Dr. Hayashi's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hayashi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →